BeOne Medicines Ltd.

Insider Reports History

Location
Basel
Signature
BeiGene, Ltd. /s/ Scott A. Samuels, SVP, General Counsel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BeOne Medicines Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. 10%+ Owner Common Stock 7,348,437 $20,943,045 $2.85 24 Sep 2021 Direct

Insider Reports Filed by BeOne Medicines Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LPTX LEAP THERAPEUTICS, INC. 24 Sep 2021 1 +$7,249,830 4 10%+ Owner 28 Sep 2021, 17:48